Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

Cirak Y. , Varol U., Atmaca H., Kisim A., Sezgin C., KARABULUT B., ...More

BJU INTERNATIONAL, vol.110, 2012 (Journal Indexed in SCI) identifier identifier identifier